Medical treatment for rectovaginal endometriosis: what is the evidence?
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Background Rectovaginal endometriosis usually causes distressing pain. Surgical treatment may be effective but is associated with a high risk of morbidity and major complications. Information on the effect of medical alternatives for pain relief in this condition is scarce. Methods A comprehensive literature search was conducted to identify all the English language published observational and randomized studies evaluating the efficacy of medical treatments on pain associated with rectovaginal endometriosis. A combination of keywords was used to identify relevant citations in PubMed, MEDLINE and EMBASE. Results A total of 217 cases of medically treated rectovaginal endometriosis were found; 68 in five observational, non-comparative studies, 59 in one patient preference cohort study, and 90 in a randomized controlled trial. An aromatase inhibitor was used in two of the non-comparative studies, vaginal danazol in one, a GnRH agonist in one, and an intrauterine progestin in one. Two estrogen-progestin combinations used transvaginally or transdermally were evaluated in the patient preference study, whereas an oral progestin and an estrogen-progestin combination were compared in the randomized controlled trial. With the exception of an aromatase inhibitor used alone, the antalgic effect of the considered medical therapies was high for the entire treatment period (from 6 to 12 months), with 60-90% of patients reporting considerable reduction or complete relief from pain symptoms. Co…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Danazole is a testosterone derivative which is used in the clinical treatment of endometriosis and induces regression of endometrial foci [4].”
From Serum levels of androgens and prostate-specific antigen in endometriosis (2014) · cites this paper as [4]
In the citing paper
“Keeping in mind the fact that endometriosis is an estrogen-dependent disease and androgen derivatives cause clinical symptomatic relief in endometriosis [3,4].”
From Serum levels of androgens and prostate-specific antigen in endometriosis (2014) · cites this paper as [4]
In the citing paper
“Hormonal treatment, including progestins or combined hormonal contraceptives, is widely used as a first-line treatment for endometriosis-associated pain [2, 27].”
From Pain and functional outcomes after surgical versus hormonal treatment in rectovaginal endometriosis: a retrospective cohort study (2026) · cites this paper as [27]
In the citing paper
“hormonal therapy appears capable of achieving improvements in patient-reported outcomes in many patients [2, 27].”
From Pain and functional outcomes after surgical versus hormonal treatment in rectovaginal endometriosis: a retrospective cohort study (2026) · cites this paper as [27]
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Mast cells synthesize, store, and release nerve growth factor.
Leon, A., Buriani, A., Dal Toso, R., Fabris, M., Romanello, S., Aloe, L., & Levi-Montalcini, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3739 · Cited by 669
Endometriosis and pelvic pain: relation to disease stage and localization
Vercellini, P., Trespidi, L., De Giorgi, O., Cortesi, I., Parazzini, F., & Crosignani, P. G. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58089-3 · Cited by 457
Self-citationCritical role of mast cells in inflammatory diseases and the effect of acute stress
Theoharides, T. C., & Cochrane, D. E. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.041 · Cited by 436
Differential release of mast cell mediators and the pathogenesis of inflammation
Theoharides, T. C., Kempuraj, D., Tagen, M., Conti, P., & Kalogeromitros, D. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00519.x · Cited by 425
The effect of surgery for symptomatic endometriosis: the other side of the story
Vercellini, P., Crosignani, P. G., Abbiati, A., Somigliana, E., Viganò, P., & Fedele, L. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmn062 · Cited by 339
Self-citationUse of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis
Fedele, L., Bianchi, S., Zanconato, G., Portuese, A., & Raffaelli, R. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01759-3 · Cited by 290
Self-citationSurgery for endometriosis-associated infertility: a pragmatic approach
Vercellini, P., Somigliana, E., Vigano, P., Abbiati, A., Barbara, G., & Crosignani, P. G. (2009) · Human Reproduction · doi:10.1093/humrep/den379 · Cited by 269
Self-citationEstradiol activates mast cells via a non-genomic estrogen receptor-α and calcium influx
Zaitsu, M., Narita, S.-I., Lambert, K. C., Grady, J. J., Estes, D. M., Curran, E. M., Brooks, E. G., Watson, C. S., Goldblum, R. M., & Midoro-Horiuti, T. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.030 · Cited by 262
Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis
Anaf, V., Chapron, C., El Nakadi, I., De Moor, V., Simonart, T., & Noël, J.-C. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.057 · Cited by 258
Research works printed but not linked: 5
- 2007, 75, 134
- 1997, Acta obstetricia et gynecologica Scandinavica, 76, 30
- 1996, Human Reproduction, 10, 2263
- 2008, Fertility and sterility, 90, 260
- 2004, The Journal of the American Association of Gynecologic Laparoscopists, 11, 127
Cited by
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Self-citationSurgical treatment of deeply infiltrating endometriosis with colorectal involvement
Meuleman, C., Tomassetti, C., D'Hoore, A., Van Cleynenbreugel, B., Penninckx, F., Vergote, I., & D'Hooghe, T. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq057 · Cited by 338
Reevaluating response and failure of medical treatment of endometriosis: a systematic review
Becker, C. M., Gattrell, W. T., Gude, K., & Singh, S. S. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.05.004 · Cited by 302
“investigated treatment outcomes for women with rectovaginal endometriosis (74).”
BackgroundInfluentialEstrogen-progestins and progestins for the management of endometriosis
Vercellini, P., Buggio, L., Berlanda, N., Barbara, G., Somigliana, E., & Bosari, S. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.022 · Cited by 243
Self-citationKondo, W., Bourdel, N., Tamburro, S., Cavoli, D., Jardon, K., Rabischong, B., Botchorishvili, R., Pouly, J., Mage, G., & Canis, M. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02774.x · Cited by 208
Medical treatment of endometriosis-related pain
Vercellini, P., Buggio, L., Frattaruolo, M. P., Borghi, A., Dridi, D., & Somigliana, E. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.015 · Cited by 188
Self-citationKnabben, L., Imboden, S., Fellmann, B., Nirgianakis, K., Kuhn, A., & Mueller, M. D. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.09.028 · Cited by 187
“Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis
Vercellini, P., Crosignani, P., Somigliana, E., Vigano, P., Frattaruolo, M. P., & Fedele, L. (2011) · Human Reproduction · doi:10.1093/humrep/deq302 · Cited by 180
“In fact, ovulation seems crucial in the development of ovarian endometriotic cysts (Jain and Dalton, 1999; Vercellini et al., 2009f), and its suppression should substantially decrease the likelihood of cyst reappearance after laparoscopic treatment.”
BackgroundInfluentialSelf-citationFerrero, S., Camerini, G., Seracchioli, R., Ragni, N., Venturini, P. L., & Remorgida, V. (2009) · Human Reproduction · doi:10.1093/humrep/dep302 · Cited by 134
Laganà, A. S., Vitale, S. G., Trovato, M. A., Palmara, V. I., Rapisarda, A. M. C., Granese, R., Sturlese, E., De Dominici, R., Alecci, S., Padula, F., et al. (2016) · BioMed Research International · doi:10.1155/2016/3617179 · Cited by 133
Vercellini, P., Somigliana, E., Consonni, D., Frattaruolo, M. P., De Giorgi, O., & Fedele, L. (2012) · Human Reproduction · doi:10.1093/humrep/des313 · Cited by 129
“However, pharmacological therapies fail in approximately one woman out of three, because of side effects, and may interfere with sexual desire and arousal (Vercellini et al., 2005, 2008, 2009c,d; Remorgida et al., 2007; Ferrero et al., 2009, 2010).”
BackgroundInfluentialSelf-citationVercellini, P., Consonni, D., Barbàra, G., Buggio, L., Frattaruolo, M. P., & Somigliana, E. (2014) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2014.02.006 · Cited by 136
“The overall major complication rate observed in the five selected studies is around 10%, which is consistent with findings of other literature reviews and with the experience of several authors (De Cicco et al., 2011; Kondo et al., 2011a; Vercellini et al., 2009b).”
BackgroundResultInfluentialSelf-citationSurgery for endometriosis: beyond medical therapies
Singh, S. S., & Suen, M. W. H. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.01.001 · Cited by 121
Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study
Ferrero, S., Camerini, G., Ragni, N., Venturini, P. L., Biscaldi, E., & Remorgida, V. (2010) · Human Reproduction · doi:10.1093/humrep/dep361 · Cited by 107
“Medical therapies (particularly progestogens and estro-progestogen combinations) have been repeatedly demonstrated to be safe, well tolerated and effective in the long-term treatment of women with symptomatic endometriosis (Vercellini et al., 2009).”
BackgroundInfluentialByrne, D., Curnow, T., Smith, P., Cutner, A., Saridogan, E., & Clark, T. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-018924 · Cited by 103
Vercellini, P., Frattaruolo, M. P., Somigliana, E., Jones, G. L., Consonni, D., Alberico, D., & Fedele, L. (2013) · Human Reproduction · doi:10.1093/humrep/det041 · Cited by 97
“Moreover, the effect of surgery is generally partial or temporary (Vercellini et al., 2000, 2009a, 2009b).”
InfluentialSelf-citationMorotti, M., Sozzi, F., Remorgida, V., Venturini, P. L., & Ferrero, S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.10.036 · Cited by 84
“Current medical therapies (including progestins) do not eradicate endometriotic lesions but they are efficacious and safe in relieving pain symptoms associated with rectovaginal endometriosis [2].”
Letrozole and norethisterone acetate in colorectal endometriosis
Ferrero, S., Camerini, G., Ragni, N., Venturini, P. L., Biscaldi, E., Seracchioli, R., & Remorgida, V. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.02.023 · Cited by 80
“Medical therapies have been shown to be safe, well tolerated and effective in long-term treatment of pain symptoms caused by deep pelvic endometriosis [11].”
BackgroundBarbàra, G., Facchin, F., Buggio, L., Somigliana, E., Berlanda, N., Kustermann, A., & Vercellini, P. (2017) · Reproductive Sciences · doi:10.1177/1933719117707054 · Cited by 100
“A total of 54 articles were excluded for the following reasons: 22 because they were studies evaluating sexual functioning after surgical or pharmacological treatment for endometriosis(20-41); 14 because no comprehensive sexual questionnaires were used and dyspareunia was the only sexual outcome evaluated or no specif…”
BackgroundSelf-citationLeone Roberti Maggiore, U., Remorgida, V., Scala, C., Tafi, E., Venturini, P. L., & Ferrero, S. (2014) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12326 · Cited by 80
Priorities for Endometriosis Research: A Proposed Focus on Deep Dyspareunia
Vercellini, P., Meana, M., Hummelshøj, L., Somigliana, E., Viganò, P., & Fedele, L. (2010) · Reproductive Sciences · doi:10.1177/1933719110382921 · Cited by 87
Self-citationSurgery versus hormonal therapy for deep endometriosis: is it a choice of the physician?
Berlanda, N., Somigliana, E., Frattaruolo, M. P., Buggio, L., Dridi, D., & Vercellini, P. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.07.513 · Cited by 74
Self-citationMorotti, M., Remorgida, V., Venturini, P. L., & Ferrero, S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.05.016 · Cited by 72
“Current medical therapies do not eradicate endometriotic lesions but they are efficacious and safe in relieving pain symptoms [1].”
BackgroundVercellini, P., Barbara, G., Buggio, L., Frattaruolo, M. P., Somigliana, E., & Fedele, L. (2012) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2012.01.003 · Cited by 67
Self-citationTreatment of infertility associated with deep endometriosis: definition of therapeutic balances
Somigliana, E., & Garcia-Velasco, J. A. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.08.003 · Cited by 66
Self-citationRole of medical therapy in the management of deep rectovaginal endometriosis
Vercellini, P., Buggio, L., & Somigliana, E. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.08.038 · Cited by 62
Self-citationBarbara, G., Facchin, F., Meschia, M., Berlanda, N., Frattaruolo, M. P., & VercellinI, P. (2017) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.13031 · Cited by 59
Self-citationBarra, F., Scala, C., Maggiore, U. L. R., & Ferrero, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010154 · Cited by 61
“Surgery is obviously required in women with rectosigmoid endometriosis at high risk of occlusion, such as patients with ultrasonographic bowel stenosis >60% or suffering subocclusive symptoms, and those with doubtful diagnosis with suspicion of bowel malignancy [22].”
BackgroundMoawad, N. S., Guido, R., Ramanathan, R., Mansuria, S., & Lee, T. (2011) · JSLS : Journal of the Society of Laparoendoscopic Surgeons · doi:10.4293/108680811x13125733356431 · Cited by 46
Combined Oral Contraceptive Therapy in Women with Posterior Deep Infiltrating Endometriosis
Mabrouk, M., Frascà, C., Geraci, E., Montanari, G., Ferrini, G., Raimondo, D., Alvisi, S., Paradisi, R., Villa, G., & Seracchioli, R. (2011) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2011.04.008 · Cited by 50
“In the last years, it has been observed that DIE responds to hormone treatment because estrogen and progesterone receptors are normally expressed in deeply infiltrating lesions [10].”
BackgroundVercellini, P., Frattaruolo, M. P., Rosati, R., Dridi, D., Roberto, A., Mosconi, P., De Giorgi, O., Cribiù, F. M., & Somigliana, E. (2018) · Human Reproduction · doi:10.1093/humrep/dex364 · Cited by 44
“Gynaecologists treated associated pelvic endometriotic lesions as usual (Vercellini et al., 2009b).”
BackgroundMethodSelf-citationTarjanne, S., Ng, C. H. M., Manconi, F., Arola, J., Mentula, M., Maneck, B., Fraser, I. S., & Heikinheimo, O. (2015) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12652 · Cited by 44
Tarjanne, S., Heikinheimo, O., Mentula, M., & Härkki, P. (2015) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12515 · Cited by 43
“The use of medical treatments for DIE has been controversial (3), but according to a recent study, hormonal therapy reduces symptoms and the volume of the nodule in DIE involving the rectum (4).”
MethodMorotti, M., Venturini, P. L., Biscaldi, E., Racca, A., Calanni, L., Vellone, V. G., Stabilini, C., & Ferrero, S. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.03.033 · Cited by 43
Yamanaka, A., Hada, T., Matsumoto, T., Kanno, K., Shirane, A., Yanai, S., Nakajima, S., Ebisawa, K., Ota, Y., & Andou, M. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.07.014 · Cited by 46
Ultrasonographic staging: a new staging system for deep endometriosis
Coccia, M. E., & Rizzello, F. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.05951.x · Cited by 46
Mast cell activation disease and the modern epidemic of chronic inflammatory disease
Afrin, L. B. (2016) · Translational Research · doi:10.1016/j.trsl.2016.01.003 · Cited by 39
“Worldwide, endometriosis is costly in terms of direct costs of care 229,230 and lost productivity.”
FERRARI, S., PERSICO, P., DI PUPPO, F., VIGANO, P., TANDOI, I., GARAVAGLIA, E., GIARDINA, P., MEZZI, G., & CANDIANI, M. (2012) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01366.x · Cited by 38
“Conversely, progestogens are known to have favorable biological effects on deep infiltrating endometriosis-associated mast cells (9).”
BackgroundResultInfluentialTriptorelin improves intestinal symptoms among patients with colorectal endometriosis
Ferrero, S., Camerini, G., Ragni, N., Menada, M. V., Venturini, P. L., & Remorgida, V. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.09.028 · Cited by 37
Estimation of the Endometriosis Fertility Index prior to operative laparoscopy
Tomassetti, C., Bafort, C., Vanhie, A., Meuleman, C., Fieuws, S., Welkenhuysen, M., Timmerman, D., Schoubroeck, D. V., & D’Hooghe, T. M. (2020) · Human Reproduction · doi:10.1093/humrep/deaa346 · Cited by 41
Is a bowel resection necessary for deep endometriosis with rectovaginal or colorectal involvement?
Acien, P., Núñez, Quereda, Velasco, Valiente, & Vidal (2013) · International Journal of Women's Health · doi:10.2147/ijwh.s46519 · Cited by 36
Management of endometriosis: Toward value-based, cost-effective, affordable care
Vercellini, P., Facchin, F., Buggio, L., Barbara, G., Berlanda, N., Frattaruolo, M. P., & Somigliana, E. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.07.011 · Cited by 36
Self-citationEmerging therapy for endometriosis
Lindsay, S. F., Luciano, D. E., & Luciano, A. A. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1051966 · Cited by 45
“LNGIUS has been shown to be effective in reducing pelvic pain and endometriotic lesions, particularly the size of rectovaginal lesions [22].”
BackgroundKondo, W., Branco, A. W., Trippia, C. H., Ribeiro, R., & Zomer, M. T. (2013) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2012.09.012 · Cited by 35
“Medical treatment plays a role in terms of pain relieve in women with DIE, leading to temporary control of the pain symptoms but not eliminating the disease [12].”
BackgroundComparison of complete and incomplete excision of deep infiltrating endometriosis.
Cao, Q., Lu, F., Feng, W., Ding, J., & Hua, K. (2015) · PubMed · Cited by 39
Endometriosis and infertility: pathophysiology, treatment strategies, and reproductive outcomes
Elizur, S. E., Mostafa, J., Berkowitz, E., & Orvieto, R. (2025) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-025-08124-1 · Cited by 58
Surgery for deep infiltrating endometriosis Technique and rationale
Kondo, W., Bourdel, N., Zomer, M. T., Slim, K., Botchorischvili, R., Rabischong, B., Mage, G., & Canis, M. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e618 · Cited by 34
Ileocecal endometriosis: clinical and pathogenetic implications of an underdiagnosed condition
Fedele, L., Berlanda, N., Corsi, C., Gazzano, G., Morini, M., & Vercellini, P. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.126 · Cited by 31
Self-citationComparison between standard and reverse laparoscopic techniques for rectovaginal endometriosis
Kondo, W., Bourdel, N., Jardon, K., Tamburro, S., Cavoli, D., Matsuzaki, S., Botchorishvili, R., Rabischong, B., Pouly, J. L., Mage, G., et al. (2011) · Surgical Endoscopy · doi:10.1007/s00464-011-1635-z · Cited by 33
“Although medical treatment in terms of pain relief in women with rectovaginal endometriosis seems to play a substantial role [3], it has a temporary effect, and highly symptomatic women usually require surgery for a more definitive result.”
BackgroundNew treatment strategies and emerging drugs in endometriosis
Streuli, I., de Ziegler, D., Borghese, B., Santulli, P., Batteux, F., & Chapron, C. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.668885 · Cited by 27
“It is now clearly demonstrated that all hormonal drugs are quite equally effective in the management of endometriosis-associated pain [24,25].”
BackgroundOutcome after surgery for deep endometriosis infiltrating the rectum
Bafort, C., van Elst, B., Neutens, S., Meuleman, C., Laenen, A., D’Hoore, A., Wolthuis, A. M., & Tomassetti, C. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.02.108 · Cited by 30
Clinical practice guidelines for the treatment of extragenital endometriosis in Japan, 2018
Hirata, T., Koga, K., Kai, K., Katabuchi, H., Kitade, M., Kitawaki, J., Kurihara, M., Takazawa, N., Tanaka, T., Taniguchi, F., et al. (2020) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14522 · Cited by 32
“A systematic review of 217 cases from 7 papers reported that 6–12 months of vaginal danazol, GnRH agonist, progestin-releasing intrauterine system and oral contraceptives (OC) were all effective in relieving pain.(6) Among seven prospective cohort studies, one evaluated the size of the lesions as an outcome, and repor…”
BackgroundBandini, V., Giola, F., Ambruoso, D., Cipriani, S., Chiaffarino, F., & Vercellini, P. (2024) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14887 · Cited by 29
“…except one in which lesion progression was also as - sessed in a group of untreated patients. difference was significant after 12 months of therapy (1.9 mL at baseline and 1.7 mL at 12 months; p = 0.001), 44 but the size returned to the baseline volume within 6 months after drug discontinuation.”
BackgroundInfluentialSelf-citationVitale, S. G., Rosa, V. L. L., Vitagliano, A., Noventa, M., Laganà, F. M., Ardizzone, A., Rapisarda, A. M. C., Terzić, M., Terzic, S., & Laganà, A. S. (2017) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/jeppd.5000303 · Cited by 26
“For the same reasons, the maintenance of hormonal suppression after surgery may be a cause of sexual dysfunction in women with DIE (59, 60).”
BackgroundIndividualized management of umbilical endometriosis: A report of seven cases
Saito, A., Koga, K., Osuga, Y., Harada, M., Takemura, Y., Yoshimura, K., Yano, T., & Kozuma, S. (2014) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.12118 · Cited by 25
Ceccaroni, M., Roviglione, G., Rosenberg, P., Pesci, A., Clarizia, R., Bruni, F., Zardini, C., Ruffo, G., Placci, A., Crippa, S., et al. (2012) · Videosurgery and Other Miniinvasive Techniques · doi:10.5114/wiitm.2011.26758 · Cited by 24
“75 mg), followed by continuative oral oestrogen and progestogen, as is routinely suggested after surgery in patients with deep endometriosis [31, 32].”
BackgroundCoccia, M. E., Rizzello, F., Palagiano, A., & Scarselli, G. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.10.004 · Cited by 26
“It has been proven that the action of progesterone on endometriotic implants could be based on a receptor-mediated effect that can reach lesions through the circulation or through direct diffusion from the producing organ [17].”
BackgroundDell’oro, M., Collinet, P., Robin, G., & Rubod, C. (2013) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2012.12.002 · Cited by 24
“En effet, l’intérêt de la chirurgie avant ou après une FIV reste controversé [3,6,13,27,28].”
BackgroundEndometriosis and Adenomyosis: Modern Concepts of Their Clinical Outcomes, Treatment, and Management
Ottolina, J., Villanacci, R., D’Alessandro, S., He, X., Grisafi, G., Ferrari, S. M., & Candiani, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13143996 · Cited by 35
“%) and avoid the risks associated with surgery, such as genital tract fistulae, bladder dysfunction, or bowel anastomotic leakage [41].”
BackgroundCeccaroni, M., Clarizia, R., Roviglione, G., Bruni, F., Ruffo, G., Peters, I., Placido, G. D., & Minelli, L. (2010) · European Journal of Obstetrics, Gynecology, and Reproductive Biology · doi:10.1016/j.ejogrb.2010.07.032 · Cited by 24
Franck, C., Poulsen, M. H., Karampas, G., Giraldi, A. G. E., & Rudnicki, M. (2018) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13369 · Cited by 26
“(15) and the recent guidelines from the National Institute for Health and Care Excellence for endometriosis (16), both medical and surgical treatments have advantages, as well as side effects and complications, respectively, for which women should be thoroughly informed.”
BackgroundManagement of deep endometriosis
Nassif, J., Trompoukis, P., Barata, S., Furtado, A., Gabriel, B., & Wattiez, A. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.08.012 · Cited by 17
Conservative approach to rectosigmoid endometriosis: a cohort study
Egekvist, A. G., Marinovskij, E., Forman, A., Kesmodel, U. S., Riiskjær, M., & Seyer‐Hansen, M. (2017) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.13094 · Cited by 15
Drechsel-Grau, A., Grube, M. P., Neis, F., Schoenfisch, B., Kommoss, S., Rall, K., Brucker, S. Y., Kraemer, B., & Andress, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175039 · Cited by 18
“Hormone-based pharmacological therapy is able to improve symptoms, and best results are achieved in combination with surgery [11–13].”
BackgroundKondo, W., Daraï, É., Yazbeck, C. M., Panel, P., Tamburro, S., Dubuisson, J. B., Jardon, K., Mage, G., Madélénat, P., & Canis, M. J. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.09.007 · Cited by 16
Endométriose profonde et infertilité, RPC Endométriose CNGOF-HAS
d’Argent, E. M., Cohen, J., Chauffour, C., Pouly, J.-L., Boujenah, J., Poncelet, C., Decanter, C., & Santulli, P. (2018) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2018.02.006 · Cited by 27
Oppenheimer, A., Boitrelle, F., Nicolás‐Boluda, A., & Fauconnier, A. (2024) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14768 · Cited by 15
Ong, H. I., Shulman, N., Nugraha, P., Wrenn, S., Nally, D., Peirce, C. B., Mahmood, U., McCormick, J. J., Proud, D. M., Warrier, S. K., et al. (2024) · International Journal of Colorectal Disease · doi:10.1007/s00384-024-04669-w · Cited by 16
“The primary approach for managing symptoms of bowel deep infiltrating endometriosis [4] involves medical therapy, including non-steroidal anti-inflammatory drugs, oral contraceptives and progestins [6, 8].”
Namazov, A., Kathurusinghe, S., Marabha, J., Merlot, B., Forestier, D., Hennetier, C., Tuech, J., & Roman, H. (2020) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2020.04.019 · Cited by 15
Hou, S., Zhang, J., Zhang, Z., Qu, H., Li, S., Jiang, Y., & Liu, C. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70216 · Cited by 14
Postmenopausal Deep Infiltrating Endometriosis of the Colon: Rare Location and Novel Medical Therapy
Snyder, B. M., Beets, J., Lessey, B. A., Horton, S. R. W., & Abrams, G. A. (2018) · Case Reports in Gastrointestinal Medicine · doi:10.1155/2018/9587536 · Cited by 14
Millischer, A., Marcellin, L., Santulli, P., Maignien, C., Bourdon, M., Borghese, B., Goffinet, F., & Chapron, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223330 · Cited by 12
Viganò, P., Vanni, V. S., Corti, L., Garavaglia, E., Tandoi, I., Pagliardini, L., Somigliana, E., & Candiani, M. (2013) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/je.5000156 · Cited by 11
Self-citationBrusic, A., Esler, S. J., Churilov, L. P., Chowdary, P., Sleeman, M. A., Maher, P. J., & Yang, N. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.108717 · Cited by 12
Rectosigmoid endometriosis: Diagnostic pitfalls and management – A case report
Piachas, A., Smyrnis, P., & Tooulias, A. I. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5222 · Cited by 9
Şevket, O., Sevket, A., Taner, T., Büyükpınarbaşılı, N., Uysal, Ö., Yılmaz, B., Dane, B., & Kelekçi, S. (2012) · Reproductive Sciences · doi:10.1177/1933719112461188 · Cited by 9
Kondo, W., Ribeiro, R., Trippia, C. H., & Zomer, M. T. (2013) · Case Reports in Obstetrics and Gynecology · doi:10.1155/2013/837903 · Cited by 10
“Hindawi Publishing Corporation Case Reports in Obstetrics and Gynecology Volume 2013, Article ID 837903, 4 pages http://dx.doi.org/10.1155/2013/837903”
InfluentialSurgical treatment of rectovaginal endometriosis with rectal involvement
Payá, V., Hidalgo‐Mora, J. J., Díaz‐García, C., & Pellicer, A. (2011) · Gynecological Surgery · doi:10.1007/s10397-011-0663-y · Cited by 10
“Clinically, although it involves a benign process, RVE can alter the quality of life for patients due to dysmenorrhea, dyspareunia, limitation of sexual activity, and the severe dyschezia that are provoked [10].”
BackgroundPodgaec, S., Baracat, E. C., & Teixeira, M. Z. (2016) · Homeopathy · doi:10.1016/j.homp.2016.03.002 · Cited by 19
The Effects of Ranibizumab on Surgically Induced Endometriosis in a Rat Model: A Preliminary Study
Şevket, O., Sevket, A., Büyükpınarbaşılı, N., Molla, T., Kilic, G., Ateş, S., & Dansuk, R. (2013) · Reproductive Sciences · doi:10.1177/1933719113483012 · Cited by 9
Mariani, L. L., Mancarella, M., Fuso, L., Baino, S., Biglia, N., & Menato, G. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05794-x · Cited by 10
Ribeiro, H. S. A. A., Maekawa, M. M., Lima, R. F., Nicola, A. L. A. D., Rodrigues, F. C. M., & Ribeiro, P. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247654 · Cited by 9
POPOUTCHI, P., JUNIOR, O. W. M., Averbach, P., FILHO, C. A. M. C., & Averbach, M. (2021) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202100000-97 · Cited by 13
Popoutchi, P., MARQUES JUNIOR, O. W., Averbach, P., CARDOSO FILHO, C. A. M., & Averbach, M. (2021) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 8
Probiotic and metronidazole treatment for recurrent bacterial vaginosis
Thulkar, J., Kriplani, A., & Agarwal, N. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.09.029 · Cited by 7
Management of endometriosis‐related pelvic pain
Hoo, W., Hardcastle, R., & Louden, K. A. (2017) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12375 · Cited by 9
Egekvist, A. G., Forman, A., Riiskjær, M., Kesmodel, U. S., Mathiasen, M., & Seyer‐Hansen, M. (2018) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13343 · Cited by 9
“patients with this phenotype often suffer from severe dysmenorrhea, dyschezia and dyspareunia (3).”
BackgroundSurgery Versus Pharmacological Treatment for Endometriosis
Avraham, S., & Seidman, D. S. (2014) · Women s Health · doi:10.2217/whe.13.77 · Cited by 10
“The levonorgestrel intrauterine system, labeled as a contraceptive and a heavy menstrual bleeding treatment, showed effectiveness in reducing endometriosis lesion severity and the size of rectovaginal lesions [20,21].”
BackgroundComparing treatments for endometriosis-related pain symptoms in patients with migraine without aura
Morotti, M., Remorgida, V., Buccelli, E., Venturini, P. L., & Ferrero, S. (2012) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.12.38 · Cited by 8
Efeito do anti-TNF-α em implantes endometriais no peritônio de ratas
Kondo, W., Lago, E. A. D., de Noronha, L., Olandoski, M., Kotze, P. G., & do Amaral, V. F. (2011) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/s0100-69912011000400011 · Cited by 8
Moustafa, M., & Elnasharty, M. A. A. (2013) · Gynecological Surgery · doi:10.1007/s10397-013-0821-5 · Cited by 6
Surgery using plasma energy for deep endometriosis: A quality of life assessment
Delbos, L., Bouet, P., Català, L., Lefebvre, C., Teyssedou, C., Descamps, P., & Legendre, G. (2018) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2018.04.005 · Cited by 7
Serum levels of androgens and prostate-specific antigen in endometriosis
Evsen, M. S., Sak, M. E., Soydinc, H. E., Guven, S., Basaranoglu, S., Hatipoglu, N. K., Evliyaoglu, O., & Gul, T. (2014) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog16712014 · Cited by 5
Use of aromatase inhibitors in menopausal deep endometriosis: a case report and literature review
Rotenberg, O. D., Kuo, D. Y.-S., & Goldberg, G. L. (2021) · Climacteric · doi:10.1080/13697137.2021.1990259 · Cited by 6
“raised possible doubt about the benefit of AI in infiltrative endometriosis [25].”
BackgroundMarcellin, L., Santulli, P., & Chapron, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820661-4.00013-3 · Cited by 5
Current Role of Surgery in Endometriosis; Indications and Progress
Kaur, K. K. (2018) · Surgical Medicine Open Access Journal · doi:10.31031/smoaj.2018.01.000521 · Cited by 5
“[26] of the International Deep Endometriosis Analysis group given on advanced ultrasound to give a guide for better imaging in this field.”
BackgroundLarraín, D., Buckel, H., Prado, J., Abedrapo, M., & Rojas, I. (2019) · Medwave · doi:10.5867/medwave.2019.11.7750 · Cited by 7
Endometriosis of the vesico-vaginal septum: a rare and unusual localization (case report)
Benkaddour, Y. A., Elfarji, A., & Soummani, A. (2020) · BMC Women s Health · doi:10.1186/s12905-020-01047-w · Cited by 5
Yang, K., Cheng, S., Cai, Y., Qiao, J., Xu, Y., Li, X., Xiong, S., Lu, Y., Mei, A., Li, X., et al. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01349-7 · Cited by 6
“Although instances of successful hormone therapy for UE have been reported [31, 32], medical treatment cannot address the fibrotic component of the lesion, which is mainly responsible for ureteral obstruction [33].”
BackgroundThe management of stage III and IV endometriosis
Elbiss, H. M., & Thomson, A. J. M. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2160-y · Cited by 4
“[41] medical treatment including, aromatase inhibitor, GnRH agonist, intrauterine progestin and COC were eVective in relieving pain in women with rectovaginal endometriosis.”
Background
Metadata
- Authors
- Vercellini, P., Crosignani, P. G., Somigliana, E., Berlanda, N., Barbara, G., & Fedele, L.
- Affiliations
- University of Milan (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Corresponding author
- Vercellini, P.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07-02
- Volume
- 24
- Issue
- 10
- Pages
- 2504-2514
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2128286983
- Cited by
- 144
- References
- 56
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 8 · 2022: 2 · 2021: 8 · 2020: 8 · 2019: 7 · 2018: 11 · 2017: 15 · 2016: 8 · 2015: 5 · 2014: 10 · 2013: 11 · 2012: 14
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- rectovaginal endometriosis, medical treatment, analgesia, aromatase inhibitors, danazol, GnRH agonist, progestins, estrogen-progestin combination, endometriosis-associated pain
- MeSH terms
- Anastrozole, Danazol, Endometriosis, Female, Humans, Intrauterine Devices, Gonadotropin-Releasing Hormone, Nitriles, Pain, Rectal Diseases, Triazoles, Vaginal Diseases, Cohort Studies, Randomized Controlled Trials as Topic, Treatment Outcome, Levonorgestrel, Aromatase Inhibitors, Patient Preference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.